MedTrace Logo

Obstructive Sleep Apnea in Obese Children and Teenagers - Occurrence and Importance of Intervention

NCT02463201 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 236

Last updated 2018-12-13

No results posted yet for this study

Summary

The prevalence of childhood obesity has increased at an alarming rate over the last decades, both globally and in Denmark. There are a number of serious sequelae related to obesity, such as hypertension, hypercholesterolemia, fatty liver and prediabetes. Obesity is found to be a risk factor for obstructive sleep apnea (OSA). OSA in childhood is known to be associated with cardiovascular complications, neurocognitive problems and reduced quality of life. The correlation between obesity and OSA is still poorly understood. Early detection and intervention is of great importance as the health consequences related to OSA as well as obesity are severe. Adenotonsillectomy is recommended as first-line therapy in children with OSA. However, only around 25% of obese children benefit from this treatment compared to around 75% of normal-weight children suggesting that there might be other structural factors predisposing to OSA in obese children.

In this study the investigators aim to clarify the impact of obesity in the development of OSA. The prevalence of OSA in obese children will be investigated. Furthermore the purpose is to assess the effect of weight loss on OSA.

Conditions

  • Sleep Apnea, Obstructive
  • Pediatric Obesity

Interventions

BEHAVIORAL

Weight loss

Sponsors & Collaborators

  • Holbaek Sygehus

    collaborator OTHER

  • Zealand University Hospital

    lead OTHER

Principal Investigators

  • Ida Andersen, MD

Eligibility

Min Age
7 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2018-02-28
Completion
2018-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02463201 on ClinicalTrials.gov